skip to main content
Show Results with:

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy

Pignolet, Béatrice et al.

Neurology -- Lippincott Williams & Wilkins -- Volume: 87 23; (pages 2491-2494) -- 2016

Online access

Searching Remote Databases, Please Wait